Nitrogen Mustard Based 2-Benzylidene-1-tetralone as ICT-Based Fluorescent Probe for Drug Release Monitoring and Cervical Cancer Therapy

Yuanwei Lianga, Chengpeng Lia, Wenhua Qiua, Puwang Lib, Ziming Yangb, Haisheng Linc, d, *, and Yuntao Zhaoc, d, **

aCollege of Chemistry and Environment, Guangdong Ocean University, Zhanjiang, 524088 China

bAgricultural Product Processing Research Institute, Chinese Academy of Tropical Agricultural Sciences, Zhanjiang, 524001 China

cCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, 524088 China

dGuangdong Provincial Key Laboratory of Aquatic Product Processing and Safety, Zhanjiang, 524088 China

email: *haishenglin@163.com
email: **zhaoyt@gdou.edu.cn

Received 30 July, 2022

Abstract— A series of novel intramolecular charge transfer (ICT) based 2-benzylidene-1-tetralones that contain nitrogen mustard for drug release monitoring and cervical cancer therapy were developed. Their emission wavelength and Stokes shift were up to 550 nm and 142 nm, respectively. These compounds exerted excellent anticancer activity against cervical cancer cells, among which 2-{4-[bis(2-chloroethyl)amino]benzylidene}-7-fluoro-3,4-dihydronaphthalen-1(2H)-one exerted the strongest anti-proliferation activity that inhibited HeLa cell cycle in G2/M phase and induced cell apoptosis, as well as activating pro-apoptotic proteins. Furthermore, the release of 2-{4-[bis(2-chloroethyl)amino]benzylidene}-7-fluoro-3,4-dihydronaphthalen-1(2H)-one probe was monitored to locate in lysosomes and nuclei.

Keywords: nitrogen mustard, drug release, fluorescent probe, cancer therapy

DOI: 10.1134/S1070363222110433